Dr. Michael Schutz, M.D

NPI: 1104872167
Total Payments
$3,165
2024 Payments
$389.24
Companies
38
Transactions
138
Medicare Patients
4,201
Medicare Billing
$391,871

Payment Breakdown by Category

Food & Beverage$3,065 (96.8%)
Consulting$100.00 (3.2%)

Payments by Nature

Nature of Payment Amount Transactions Share
Food and Beverage $3,065 137 96.8%
Consulting Fee $100.00 1 3.2%

Top Paying Companies

Company Total Records Latest Year
Astellas Pharma US Inc $292.47 20 $0 (2024)
Bayer Healthcare Pharmaceuticals Inc. $269.08 8 $0 (2024)
Janssen Biotech, Inc. $250.63 12 $0 (2022)
Medtronic USA, Inc. $245.13 3 $0 (2019)
ABBVIE INC. $191.22 14 $0 (2024)
Boston Scientific Corporation $181.08 3 $0 (2019)
Palette Life Sciences, Inc. $179.48 4 $0 (2022)
NeoTract Inc. $137.38 2 $0 (2018)
Daiichi Sankyo Inc. $113.85 6 $0 (2024)
PFIZER INC. $105.63 2 $0 (2019)

Payment History by Year

Year Amount Transactions Top Company
2024 $389.24 21 Daiichi Sankyo Inc. ($60.22)
2023 $338.83 20 Astellas Pharma US Inc ($65.95)
2022 $595.73 32 Palette Life Sciences, Inc. ($179.48)
2021 $153.16 9 Medtronic, Inc. ($41.48)
2020 $43.06 3 Amgen Inc. ($43.06)
2019 $514.35 6 Boston Scientific Corporation ($181.08)
2018 $278.05 11 NeoTract Inc. ($111.70)
2017 $852.49 36 Janssen Biotech, Inc. ($185.11)

All Payment Transactions

138 individual payment records from CMS Open Payments — Page 1 of 6

Date Company Product Nature Form Amount Type
09/23/2024 Astellas Pharma US Inc Xtandi (Drug) Food and Beverage In-kind items and services $14.94 General
Category: Oncology
09/16/2024 Daiichi Sankyo Inc. Enhertu (Drug) Food and Beverage In-kind items and services $16.67 General
Category: ONCOLOGY
09/06/2024 AstraZeneca Pharmaceuticals LP ENHERTU (Biological) Food and Beverage In-kind items and services $16.98 General
Category: Oncology
09/04/2024 Stemline Therapeutics Inc. Orserdu (Drug) Food and Beverage In-kind items and services $16.94 General
Category: Oncology
08/27/2024 JAZZ PHARMACEUTICALS INC. ZEPZELCA (Drug) Food and Beverage In-kind items and services $18.94 General
Category: HEMATOLOGY/ONCOLOGY
08/23/2024 ABBVIE INC. LUPRON DEPOT (Drug) Food and Beverage In-kind items and services $18.59 General
Category: ENDOCRINOLOGY
08/19/2024 Daiichi Sankyo Inc. INJECTAFER (Drug) Food and Beverage In-kind items and services $18.60 General
Category: Iron Deficiency Anemia
07/29/2024 Sumitomo Pharma America, Inc. ORGOVYX (Drug) Food and Beverage In-kind items and services $14.45 General
Category: HORMONE THERAPY
07/16/2024 AstraZeneca Pharmaceuticals LP CALQUENCE (Drug) Food and Beverage In-kind items and services $18.98 General
Category: Oncology
06/25/2024 Daiichi Sankyo Inc. Enhertu (Drug) Food and Beverage In-kind items and services $24.95 General
Category: ONCOLOGY
06/11/2024 Novocure Inc. Optune (Device) Food and Beverage Cash or cash equivalent $24.26 General
Category: Oncology
06/06/2024 Stemline Therapeutics Inc. Orserdu (Drug) Food and Beverage In-kind items and services $16.05 General
Category: Oncology
05/23/2024 Merck Sharp & Dohme LLC KEYTRUDA (Biological) Food and Beverage In-kind items and services $17.56 General
Category: ONCOLOGY
05/06/2024 Astellas Pharma US Inc Xtandi (Drug) Food and Beverage In-kind items and services $13.93 General
Category: Oncology
04/05/2024 Adaptive Biotechnologies Corporation clonoSEQ (Device) Food and Beverage Cash or cash equivalent $24.80 General
Category: ONCOLOGY
03/15/2024 Bayer Healthcare Pharmaceuticals Inc. Nubeqa (Drug), Xofigo Food and Beverage In-kind items and services $17.35 General
Category: Oncology
03/12/2024 Astellas Pharma US Inc Xtandi (Drug) Food and Beverage In-kind items and services $13.77 General
Category: Oncology
03/08/2024 Novocure Inc. Optune (Device) Food and Beverage Cash or cash equivalent $32.06 General
Category: Oncology
01/22/2024 Astellas Pharma US Inc Xtandi (Drug) Food and Beverage In-kind items and services $13.31 General
Category: Oncology
01/18/2024 Merck Sharp & Dohme LLC KEYTRUDA (Biological), LYNPARZA Food and Beverage In-kind items and services $19.69 General
Category: ONCOLOGY
01/17/2024 AstraZeneca Pharmaceuticals LP ENHERTU (Biological) Food and Beverage In-kind items and services $16.42 General
Category: Oncology
12/13/2023 Astellas Pharma US Inc Padcev (Drug) Food and Beverage In-kind items and services $16.66 General
Category: Oncology
12/08/2023 Daiichi Sankyo Inc. Enhertu (Drug) Food and Beverage In-kind items and services $24.95 General
Category: ONCOLOGY
11/09/2023 MorphoSys, US Inc. MONJUVI (Drug) Food and Beverage In-kind items and services $16.10 General
Category: Oncology
10/26/2023 Lilly USA, LLC VERZENIO (Drug), JAYPIRCA Food and Beverage In-kind items and services $17.00 General
Category: Oncology

Medicare Billing by Year

Year Procedures Beneficiaries Services Submitted Medicare Paid
2023 14 632 689 $144,073 $55,779
2022 17 885 1,002 $195,075 $83,187
2021 25 1,121 3,571 $296,859 $115,929
2020 29 1,563 3,780 $396,754 $136,975
Total Patients
4,201
Total Services
9,042
Medicare Billing
$391,871
Procedure Codes
92

All Medicare Procedures & Services

92 procedure records from CMS Medicare Utilization — Page 2 of 4

HCPCS Description Setting Year Patients Services Charges Medicare Paid Ratio
99221 Initial hospital inpatient care per day, typically 30 minutes Facility 2022 34 34 $6,548 $2,899 44.3%
51797 Insertion of device into abdomen with pressure and urine flow rate study Office 2022 15 15 $6,000 $2,729 45.5%
76856 Complete ultrasound scan of pelvis Office 2022 20 20 $4,000 $1,708 42.7%
51728 Complex measurement of pressure of urine flow in bladder with voiding pressure studies Facility 2022 17 17 $4,462 $1,504 33.7%
76770 Complete ultrasound scan behind abdominal cavity Office 2022 17 18 $3,600 $1,415 39.3%
99232 Follow-up hospital inpatient care per day, typically 25 minutes Facility 2022 17 18 $2,448 $972.19 39.7%
51702 Simple insertion of temporary bladder tube Office 2022 14 19 $3,020 $957.96 31.7%
99212 Established patient office or other outpatient visit, 10-19 minutes Office 2022 11 15 $1,625 $741.70 45.6%
51797 Insertion of device into abdomen with pressure and urine flow rate study Facility 2022 17 17 $1,876 $577.68 30.8%
51784 Non-needle measurement and recording of electrical activity of muscles at bladder and bowel openings Office 2022 17 17 $6,800 $510.01 7.5%
51784 Non-needle measurement and recording of electrical activity of muscles at bladder and bowel openings Facility 2022 18 18 $1,467 $287.13 19.6%
51741 Electronic assessment of bladder emptying Office 2022 30 30 $6,000 $247.01 4.1%
51741 Electronic assessment of bladder emptying Facility 2022 32 33 $770.10 $149.55 19.4%
99213 Established patient outpatient visit, total time 20-29 minutes Office 2021 236 355 $44,917 $26,788 59.6%
52000 Diagnostic examination of the bladder and bladder canal (urethra) using an endoscope Office 2021 84 85 $42,500 $18,329 43.1%
J9217 Leuprolide acetate (for depot suspension), 7.5 mg Office 2021 14 85 $26,227 $11,125 42.4%
76770 Ultrasound behind abdominal cavity Office 2021 107 108 $21,600 $10,186 47.2%
76856 Ultrasound of pelvis, complete, not pregnancy related Office 2021 88 90 $18,000 $8,552 47.5%
51728 Complex measurement of pressure of urine flow in bladder (cystometrogram) with voiding pressure studies Office 2021 17 17 $10,200 $5,704 55.9%
99203 New patient outpatient visit, total time 30-44 minutes Office 2021 63 63 $12,291 $5,357 43.6%
J9030 Bcg live intravesical instillation, 1 mg Office 2021 19 2,200 $11,000 $4,869 44.3%
55700 Biopsy of prostate gland Facility 2021 34 34 $15,565 $3,643 23.4%
51720 Instillation of anti-cancer drug into bladder Office 2021 19 44 $10,560 $3,512 33.3%
99214 Established patient outpatient visit, total time 30-39 minutes Office 2021 23 27 $5,078 $2,852 56.2%
51797 Insertion of device into the abdomen with measurement of pressure and urine flow rate Office 2021 13 13 $5,200 $2,274 43.7%

About Dr. Michael Schutz, M.D

Dr. Michael Schutz, M.D is a Urology healthcare provider based in Somers Point, New Jersey. This provider has been registered with the National Plan and Provider Enumeration System (NPPES) since 05/25/2006. The National Provider Identifier (NPI) number assigned to this provider is 1104872167.

According to the Centers for Medicare & Medicaid Services (CMS) Open Payments database, Dr. Michael Schutz, M.D has received a total of $3,165 in payments from pharmaceutical and medical device companies, with $389.24 received in 2024. These payments were reported across 138 transactions from 38 companies. The most common payment nature is "Food and Beverage" ($3,065).

As a Medicare-enrolled provider, Schutz has provided services to 4,201 Medicare beneficiaries, totaling 9,042 services with total Medicare billing of $391,871. Data is available for 4 years (2020–2023), covering 92 distinct procedure/service records.

Practice Information

  • Specialty Urology
  • Location Somers Point, NJ
  • Active Since 05/25/2006
  • Last Updated 02/24/2011
  • Taxonomy Code 208800000X
  • Entity Type Individual
  • NPI Number 1104872167

Products in Payments

  • INTERSTIM (Device) $286.61
  • ZYTIGA (Drug) $223.80
  • KEYTRUDA (Biological) $203.06
  • Xofigo (Drug) $169.41
  • Xtandi (Drug) $157.22
  • REZUM (Device) $154.68
  • UroLift (Device) $111.70
  • XTANDI (Drug) $103.57
  • LUPRON DEPOT (Drug) $98.68
  • Nubeqa (Drug) $79.88
  • PROVENGE (Drug) $77.76
  • JAKAFI (Drug) $70.70
  • Androgel (Drug) $69.12
  • Enhertu (Drug) $66.57
  • VERZENIO (Drug) $64.51
  • Optune (Device) $56.32
  • Padcev (Drug) $48.84
  • CALQUENCE (Drug) $48.16
  • Myrbetriq (Drug) $47.29
  • INJECTAFER (Drug) $47.28

Data Sources

Provider data from NPPES. Payment data from CMS Open Payments. Medicare data from CMS Medicare Provider Utilization. All data is public and updated periodically.

Urology Doctors in Somers Point